Literature DB >> 23134580

Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer.

Arden L Corter1, Michael Findlay, Reuben Broom, David Porter, Keith J Petrie.   

Abstract

OBJECTIVES: Adjuvant endocrine therapy for early-stage breast cancer has greatly reduced the morbidity and mortality associated with breast cancer recurrence. Despite this, a significant proportion of women report fears of cancer recurrence. This study examined the associations between fear of cancer recurrence (FoR) and illness perceptions, medication beliefs, and treatment side effects in women taking adjuvant endocrine therapy following breast cancer.
METHODS: A total of 153 post-menopausal women with early-stage breast cancer completed a postal survey. Analyses were conducted to examine the association between FoR and illness perceptions, medication beliefs, treatment side effects, demographic factors, and emotional distress and to identify which of these factors would be most strongly associated with FoR in a regression model.
RESULTS: All illness perceptions (apart from personal control) were associated with FoR, as were patient beliefs about endocrine therapy. Although treatment side effects, being unemployed, and higher levels of anxiety and depression were associated with FoR, only illness perceptions (identity, treatment control, timeline, and emotional representation) and medication necessity beliefs were significantly correlated with FoR in the final model.
CONCLUSIONS: It appears that, in addition to directly targeting FoR, it may be worthwhile to address the illness and medication beliefs supporting the fear. Additionally, helping women to differentiate everyday symptoms from those indicative of breast cancer may help to reduce fear of recurrence. STATEMENT OF CONTRIBUTION: What is already known on this subject? A significant proportion of women report fear of cancer recurrence following breast cancer. The literature shows that illness perceptions, side effects of treatment, and beliefs about medicines are related to fear of recurrence among cancer patients. However, because these variables have often been looked at in isolation, it is not clear whether some perceptions or cues are more likely to relate to fear of recurrence than others. What does this study add? This study shows illness perceptions and medication beliefs are strongly related to fears of cancer recurrence. The results point to ways in which the self-regulatory model of illness may be used to reduce patients' fear of recurrence. The study results show that women with higher fear of recurrence may be balancing a tension between believing that they need to take the medication to protect their future health alongside concerns that the treatment may not be working.
© 2012 The British Psychological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23134580     DOI: 10.1111/bjhp.12003

Source DB:  PubMed          Journal:  Br J Health Psychol        ISSN: 1359-107X


  18 in total

Review 1.  Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation.

Authors:  Joanna E Fardell; Belinda Thewes; Jane Turner; Jemma Gilchrist; Louise Sharpe; Allan 'Ben' Smith; Afaf Girgis; Phyllis Butow
Journal:  J Cancer Surviv       Date:  2016-01-19       Impact factor: 4.442

2.  Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.

Authors:  Shoshana M Rosenberg; Annette L Stanton; Keith J Petrie; Ann H Partridge
Journal:  Oncologist       Date:  2015-05-01

3.  Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy.

Authors:  Clémentine Lopez; Cécile Charles; Pascal Rouby; Diane Boinon; Sophie Laurent; Annie Rey; Marc Spielmann; Sarah Dauchy
Journal:  Support Care Cancer       Date:  2015-04-17       Impact factor: 3.603

4.  Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.

Authors:  Caitriona Cahir; Stephan U Dombrowski; Catherine M Kelly; M John Kennedy; Kathleen Bennett; Linda Sharp
Journal:  Support Care Cancer       Date:  2015-03-07       Impact factor: 3.603

5.  Illness perception is a strong parameter on anxiety and depression scores in early-stage breast cancer survivors: a single-center cross-sectional study of Turkish patients.

Authors:  Tulay Kus; Gokmen Aktas; Hatice Ekici; Gulcin Elboga; Sabire Djamgoz
Journal:  Support Care Cancer       Date:  2017-05-26       Impact factor: 3.603

6.  Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal.

Authors:  L Curran; L Sharpe; C MacCann; P Butow
Journal:  J Behav Med       Date:  2020-01-06

7.  Racial and ethnic disparities in post-traumatic stress and illness coherence in breast cancer survivors with comorbid diabetes.

Authors:  Melissa Mazor; Juan P Wisnivesky; Mita Goel; Yael Tobi Harris; Jenny J Lin
Journal:  Psychooncology       Date:  2021-06-14       Impact factor: 3.955

Review 8.  Illness Perceptions in Women with Breast Cancer-a Systematic Literature Review.

Authors:  Ad A Kaptein; Jan W Schoones; Maarten J Fischer; Melissa S Y Thong; Judith R Kroep; Koos J M van der Hoeven
Journal:  Curr Breast Cancer Rep       Date:  2015

9.  Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy.

Authors:  Sujin Ha; Eunjung Ryu
Journal:  Asia Pac J Oncol Nurs       Date:  2021-04-24

10.  Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.

Authors:  M J Fischer; K Inoue; A Matsuda; J R Kroep; S Nagai; K Tozuka; M Momiyama; N I Weijl; D Langemeijer-Bosman; S R S Ramai; J W R Nortier; H Putter; K Yamaoka; K Kubota; K Kobayashi; A A Kaptein
Journal:  Breast Cancer Res Treat       Date:  2017-07-31       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.